Clinical Trial Support Services Global Market Report 2025

The clinical trial support services market size has grown strongly in recent years. It will grow from $22.62 billion in 2024 to $24.55 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the increasing outsourcing of clinical trials, rising healthcare expenditures, expansion of the pharmaceutical and biotechnology sectors, regulatory changes and reforms, globalization of clinical trials, the growing prevalence of diseases, increased clinical research funding, and the rising demand for faster drug development.

The clinical trial support services market size is expected to see rapid growth in the next few years. It will grow to $33.68 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to the rising demand for personalized medicine, the increasing prevalence of chronic diseases, higher investments in research and development, regulatory support for clinical trials, the expansion of outsourcing in clinical research, a growing emphasis on patient-centric trials, the increasing complexity of clinical trials, and the emergence of new therapeutic areas. Key trends expected during this period include the integration of artificial intelligence and machine learning, the adoption of blockchain technology and big data analytics, the use of wearable devices, the rise of decentralized clinical trials, advancements in electronic data capture and clinical trial management systems, as well as the expansion of remote patient monitoring and virtual clinical trials.

The rise of personalized medicine is expected to drive the growth of the clinical trial support services market in the coming years. Personalized medicine involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and enhance care. The increasing adoption of personalized medicine is fueled by advancements in genomics, the growing availability of biomarker-based diagnostics, improved data analytics technologies, and a rising demand for targeted and effective therapies. Clinical trial support services play a crucial role in facilitating personalized medicine by optimizing patient recruitment, implementing biomarker-driven trial designs, and ensuring regulatory compliance, thereby enabling the development of therapies tailored to individual genetic and disease profiles. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized treatments in 2023, a significant rise from the 12 approved in 2022. As a result, the growing emphasis on personalized medicine is fueling the expansion of the clinical trial support services market.

Leading companies in the clinical trial support services market are increasingly focusing on developing patient-centric trials to improve recruitment, enhance retention, minimize participant burden, and create a more inclusive and positive experience for diverse patient populations. Patient-centric trials are clinical studies designed to prioritize the needs, preferences, and experiences of patients, improving accessibility, engagement, and overall participant satisfaction throughout the trial process. For example, in March 2023, Leal Health, a US-based patient-first digital health company, introduced a groundbreaking patient-centric program-level analytics platform. This platform integrates with pharmaceutical companies’ online clinical trial websites, enabling them to develop and execute effective, patient-focused programs to ensure high-quality patient candidates, reduce recruitment timelines, and achieve operational efficiencies for a seamless end-to-end patient experience.

In February 2024, ICON plc, an Ireland-based clinical research organization, acquired Clinical Research Management Inc. for an undisclosed amount. This acquisition strengthens ICON’s ability to access the market for government-sponsored research while expanding its expertise in vaccines and infectious disease research. Clinical Research Management Inc. is a US-based contract research organization (CRO) that specializes in providing clinical research and trial services.

Major players in the clinical trial support services market are Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi S.A., Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Iqvia Inc., Laboratory Corporation of America Holdings (Labcorp), ICON plc, SGS S.A., Eurofins Scientific SE, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International Inc., Medpace Holdings Inc., Pharmaron, MARKEN Ltd., Novotech, ClinChoice Private Limited, Medidata Solutions Inc., Premier Research, Quotient Sciences Ltd., Caidya, MMS Holdings Inc., Celerion Inc., Parexel International (MA) Corporation, Alcura Health, Almac Group, Brighter Health Network LLC, and.

North America was the largest region in the clinical trial support services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in clinical trial support services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the clinical trial support services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Clinical trial support services encompass a range of specialized solutions designed to aid in the planning, execution, and management of clinical trials, ensuring regulatory compliance, data integrity, patient recruitment, and overall trial efficiency. These services help streamline the drug development process, minimize operational complexities, and improve the quality and reliability of trial outcomes.

The primary services in the clinical trial support services market include clinical trial site management, data management, patient recruitment management, administrative staff, institutional review board (IRB) services, and others. Clinical trial site management involves coordinating and overseeing all activities at a trial site to ensure regulatory compliance, adherence to protocols, and efficient trial execution. These services span different trial phases, including preclinical studies, Phase I, Phase II, Phase III, and Phase IV, and are applied across various therapeutic areas such as oncology, central nervous system (CNS) and mental disorders, cardiovascular diseases, infectious diseases, blood disorders, and more.

The clinical trial support services market research report is one of a series of new reports that provides clinical trial support services market statistics, including clinical trial support services industry global market size, regional shares, competitors with a clinical trial support services market share, detailed clinical trial support services market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial support services industry. This clinical trial support services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical trial support services market includes revenues earned by entities by providing services such as regulatory affairs and compliance, medical writing and documentation, pharmacovigilance and safety monitoring, biostatistics and data analysis, quality assurance and auditing, and eClinical solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.